Gefitinib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Biological therapies such as gefitinib may interfere with the growth of the tumor cells and
slow the growth of glioblastoma multiforme. Phase II trial to study the effectiveness of
gefitinib in treating patients who have newly diagnosed glioblastoma multiforme.